Text Correction
In the published article, there was an error. One of the citations of Table 3 was incorrect and should have referred to Table 4 instead.
A correction has been made to the Results section, Association between regional failure (distant brain failure) and other variables, paragraph 1. This sentence previously stated:
“After univariate analyses, age at diagnosis, histology, MRI maximum axial dimension, time interval between diagnostic MRI and first treatment, time interval between CT simulation and first treatment, fractionated versus single fraction SRS, total dose, GTV, PTV, max GTV dose, presence of normal brain constraint, and a history of prior WBRT were not associated with regional failure (Table 3).”
The corrected sentence appears below:
“After univariate analyses, age at diagnosis, histology, MRI maximum axial dimension, time interval between diagnostic MRI and first treatment, time interval between CT simulation and first treatment, fractionated versus single fraction SRS, total dose, GTV, PTV, max GTV dose, presence of normal brain constraint, and a history of prior WBRT were not associated with regional failure (Table 4).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
stereotactic radiosurgery, brain metastases, immunotherapy, radionecrosis, treatment delays, cancer, radiation therapy, radiation necrosis
Citation
Leu J, Akerman M, Mendez C, Lischalk JW, Carpenter T, Ebling D, Haas JA, Witten M, Barbaro M, Duic P, Tessler L and Repka MC (2023) Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure. Front. Oncol. 13:1192726. doi: 10.3389/fonc.2023.1192726
Received
23 March 2023
Accepted
29 March 2023
Published
05 April 2023
Volume
13 - 2023
Edited and reviewed by
John Varlotto, Edwards Comprehensive Cancer Center, United States
Updates
Copyright
© 2023 Leu, Akerman, Mendez, Lischalk, Carpenter, Ebling, Haas, Witten, Barbaro, Duic, Tessler and Repka.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Michael C. Repka, michael_repka@med.unc.edu
This article was submitted to Radiation Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.